Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control.

This study presents the first data in the use of a pharmacobehavioral intervention that capitalize on the benefits of open-label placebo and classical drug conditioning for opioid dose reduction in a population with moderate to severe pain exposed to intensive inpatient rehabilitation.